In recognition of World Rare Disease Day (the last day of February), the US Food and Drug Administration and European Medicines Agency have agreed to jointly accept a single annual report for drugs that have obtained orphan drug designation. The decision should streamline the development of drugs for rare diseases.
EMA press release (pdf)